在自身免疫神经肌肉疾病当前的生物标志物策略
Menekse Oeztuerk1, Antonia Henes1, Christina B Schroeter1
1Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Cells
|October 27, 2023
概括
生物标志物对于诊断和管理诸如GBS和CIDP之类的炎症性神经肌肉疾病至关重要. 需要进一步的研究来开发更具体的生物标志物,以改善患者护理.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 炎症神经肌肉疾病是免疫媒介疾病,呈现方式多样化.
- 生物标志物对于在这些罕见而异质的疾病中进行诊断,预后和治疗监测至关重要.
研究的目的:
- 审查已确立的吉兰-巴雷综合征 (GBS),慢性炎症性脱髓性多神经病 (CIDP),严重肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛性肌痛 (MG) 的生物标志物.
- 突出现有的诊断,预后和预测生物标志物,并确定对新型标志物的未满足需求.
主要方法:
- 在GBS,CIDP,MG和IIM中对生物标志物的综合文献综述.
- 对当前生物标志物的实用性,局限性和挑战进行分析.
主要成果:
- 现有的生物标志物有助于诊断和管理,但由于疾病异质性而不足.
- 在这些疾病中,对于更具体,更可靠的生物标志物存在重大未满足的需求.
结论:
- 生物标志物有望增强炎症神经肌肉疾病的管理.
- 新的策略和进一步的研究对于开发用于个性化治疗的临床上有意义的生物标志物至关重要.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
924
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
924
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K